Why is Emmessar Biotech falling/rising?

As of 24-Sep, Emmessar Biotech & Nutrition Ltd's stock price is currently at 35.49, reflecting an increase of 0.32 or 0.91%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this positive movement today, the stock has underperformed in the short term, with a 1-week return of -8.72%. However, it has performed well over the past month, with a return of +22.85%. The stock is currently trading above its 20-day, 50-day, 100-day, and 200-day moving averages, but below its 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume falling by 85.84% compared to the 5-day average, indicating reduced trading interest.
Broader market context shows that while Emmessar Biotech has outperformed its sector by 1.4% today, its recent performance over the year has been negative, with a decline of -11.25%, compared to a slight decline of -3.77% in the benchmark index, Sensex. The stock's year-to-date performance is also concerning, with a drop of -23.35%, contrasting with the Sensex's gain of +4.58%. This suggests that while there may be short-term positive movements, the overall trend for Emmessar Biotech remains weak compared to the broader market, reflecting challenges that may be affecting investor sentiment.